1 / 8

Rectal Cancer - Pipeline Review, H2 2015 – Aarkstore.com

The Rectal Cancer-Pipeline Review, H2 2015 includes key players, projects, global landscape, product descriptions, stage developments, strategic initiatives, business potential, collaboration/licensing details, latest updates, operational activities, competitor information, portfolios, therapeutics etc.

michaelb
Download Presentation

Rectal Cancer - Pipeline Review, H2 2015 – Aarkstore.com

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rectal Cancer - Pipeline Review, H2 2015

  2. Summary ‘Rectal Cancer - Pipeline Review, H2 2015’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Rectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rectal Cancer and special features on late-stage and discontinued projects. Scope - The report provides a snapshot of the global therapeutic landscape of Rectal Cancer - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities  - The report reviews key players involved in the therapeutics development for Rectal Cancer and enlists all their major and minor projects

  3.  Table of Content List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Rectal Cancer Overview 6 Therapeutics Development 7 Pipeline Products for Rectal Cancer - Overview 7 Pipeline Products for Rectal Cancer - Comparative Analysis 8 Rectal Cancer - Therapeutics under Development by Companies 9 Rectal Cancer - Pipeline Products Glance 10 Clinical Stage Products 10 Early Stage Products 11 Rectal Cancer - Products under Development by Companies 12 Rectal Cancer - Companies Involved in Therapeutics Development 13AbbVie Inc. 13 Cerulean Pharma, Inc. 14

  4. List Of Tables  Number of Products under Development for Rectal Cancer, H2 2015 7 Number of Products under Development for Rectal Cancer - Comparative Analysis, H2 2015 8 Number of Products under Development by Companies, H2 2015 9 Comparative Analysis by Clinical Stage Development, H2 2015 10 Comparative Analysis by Early Stage Development, H2 2015 11 Products under Development by Companies, H2 2015 12 Rectal Cancer - Pipeline by AbbVie Inc., H2 2015 13 Rectal Cancer - Pipeline by Cerulean Pharma, Inc., H2 2015 14 Rectal Cancer - Pipeline by Hanwha Chemical Corporation, H2 2015 15 Rectal Cancer - Pipeline by Incuron, LLC, H2 2015 16 Rectal Cancer - Pipeline by Karyopharm Therapeutics, Inc., H2 2015 17 Rectal Cancer - Pipeline by Nanobiotix, H2 2015 18 Rectal Cancer - Pipeline by Peregrine Pharmaceuticals, Inc., H2 2015 19 Rectal Cancer - Pipeline by Regeneron Pharmaceuticals, Inc., H2 2015 20 Rectal Cancer - Pipeline by Synta Pharmaceuticals Corp., H2 2015 21 Assessment by Monotherapy Products, H2 2015 22 Number of Products by Stage and Target, H2 2015 24

  5. List Of Figures Number of Products under Development for Rectal Cancer, H2 2015 7 Number of Products under Development for Rectal Cancer - Comparative Analysis, H2 2015 8 Number of Products under Development by Companies, H2 2015 9 Comparative Analysis by Clinical Stage Development, H2 2015 10 Assessment by Monotherapy Products, H2 2015 22 Number of Products by Top 10 Targets, H2 2015 23 Number of Products by Stage and Top 10 Targets, H2 2015 23 Number of Products by Top 10 Mechanism of Actions, H2 2015 25 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 25 Browse full report Or Sample Request @ • http://www.aarkstore.com/pharmaceuticals-healthcare/46964/rectal-cancer-pipeline-review-h2-2015

  6. Related Reports • Global Insulin Industry 2015 Market Research Report • EpiCast Report: Fabry Disease - Epidemiology Forecast to 2024 • EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2024 • Investigation Report on China Atracurium Market, 2010-2019 • Investigation Report on China Temozolomide Market, 2010-2019

  7. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise

  8. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com

More Related